Evidence map›Paper›PMID 42352307›Full record

ReviewBiomolecules2026

Recent Advances in Atomic-Resolution NMR Investigations of Monoclonal Antibodies.

Béatrice Vibert, Faustine Henot, Oriane Frances, Jérôme Boisbouvier

Abstract readReview
In one paragraph

Review in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Béatrice VibertInstitut de Biologie Structurale (IBS), Université Grenoble Alpes, CNRS, CEA, 38044 Grenoble, France.ORCID 0000-0002-3317-2963
Faustine HenotIntegrated Drug Discovery Department, Sanofi R&D, 94400 Vitry-sur-Seine, France.
Oriane FrancesIntegrated Drug Discovery Department, Sanofi R&D, 94400 Vitry-sur-Seine, France.
Jérôme BoisbouvierInstitut de Biologie Structurale (IBS), Université Grenoble Alpes, CNRS, CEA, 38044 Grenoble, France.ORCID 0000-0003-3278-3639

Funding

Agence Nationale de la Recherche ANR-15- IDEX-02Agence Nationale de la Recherche ANR-22-CE29-0024-01
6 · The paper itself

Abstract

Monoclonal antibodies (mAbs) have been the subject of extensive study in recent years due to their recognition as highly promising therapeutic molecules offering high specificity and a low risk of side effects. Monitoring the structure of these molecules is crucial for developing new therapeutics, characterizing interactions with antigens or receptors, and explaining potential changes in activity between antibody production batches. However, commonly used biophysical approaches provide only low-spatial-resolution information, and conventional structural biology techniques such as crystallography and cryo-electron microscopy (cryo-EM) are difficult to apply to these highly dynamic proteins. Solution nuclear magnetic resonance (NMR) spectroscopy is the method of choice for structural studies of flexible proteins at atomic resolution; however, it has traditionally been limited to low-molecular-weight biological systems. In this review, we present recent advances in NMR spectroscopy and advanced isotopic labeling methods that have enabled the atomic-resolution study of both the crystallizable (Fc) and antigen-binding (Fab) fragments of antibodies. We show how NMR is becoming a powerful tool for investigating full-length mAbs at an atomic level, opening up new possibilities for the characterization and in-depth quality control of therapeutic antibodies in solution.

Indexed as

Antibodies, MonoclonalNuclear Magnetic Resonance, BiomolecularAnimalsHumansImmunoglobulin Fab FragmentsMagnetic Resonance SpectroscopyProtein ConformationAntibodies, MonoclonalImmunoglobulin Fab FragmentsFabFcfingerprintsHOSisotopic labelingmAbsmethyl groupsNMRresonance assignment

Identifiers

PMID42352307
PMCPMC13297149

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.